Black women with endometrial cancer have more advanced disease and les
s favorable tumor grade than do white women. This study evaluated whet
her racial differences in tumor grade could be explained by hormone-re
lated factors and other putative determinants of grade. Subjects inclu
ded 207 white and 81 black postmenopausal women diagnosed with primary
cancer of the uterine corpus between 1985 and 1987. Blacks had poorer
tumor grade than whites (odds ratio for FIGO grade 2 versus grade 1 i
s 1.8; odds ratio for grade 3 versus grade 1 is 2.8). Over 75% of the
excess of poorly differentiated tumors versus well-differentiated tumo
rs among blacks could be explained by racial differences in use of rep
lacement estrogens, age at first pregnancy, history of oophorectomy, p
overty, stage of disease, use of screening, and access to health care.
The most prominent factor was estrogen therapy, which was associated
with favorable tumor grade and was used much less frequently by blacks
. Although not statistically significant, a moderate racial difference
in tumor grade remained after control of the potential explanatory va
riables. This may reflect true biologic variation between blacks and w
hites and may explain, in part, the observation that blacks with endom
etrial cancer have a worse prognosis. (C) 1995 Academic Press, Inc.